Introduction & Etiology

  • Contamination outbreaks of pediatric acute kidney injury (AKI) and deaths have occurred globally (Gambia, Uzbekistan, Indonesia) and historically in India (Gurgaon, Jammu, Mumbai).
  • Etiology: Adulteration or substitution of pharmaceutical solvent excipients (Propylene Glycol and Glycerol) with industrial-grade Diethylene Glycol (DEG) and Ethylene Glycol (EG) in pediatric oral formulations (cough/cold and paracetamol syrups).
  • Regulatory & Clinical Response: WHO Medical Product Alerts, revised CDSCO Schedule M Good Manufacturing Practices mandating raw-material testing, and IAP guidelines advising against over-the-counter (OTC) cough and cold formulations in young children.

Pathophysiology And Toxicokinetics Of Diethylene Glycol (DEG)

flowchart TD
    A["Diethylene Glycol (DEG) Ingestion"] --> B["Hepatic Metabolism via<br><b>Alcohol Dehydrogenase (ADH)</b>"]
    
    B --> C["2-Hydroxyethoxyacetaldehyde"]
    C --> D["Aldehyde Dehydrogenase (ALDH)"]
    D --> E["<b>2-Hydroxyethoxyacetic Acid (HEAA)</b><br><i>(Primary Toxic Metabolite)</i>"]
    
    E --> F["<b>Severe Anion-Gap Metabolic Acidosis</b><br>High Osmolar Gap early, transitioning to High Anion Gap"]
    E --> G["<b>Direct Renal Tubular Toxicity</b><br>Acute Tubular Necrosis (ATN) → Oliguria / Anuria"]
    E --> H["<b>Neurotoxicity</b><br>Encephalopathy, facial nerve palsy, peripheral motor neuropathy"]
    
    subgraph Antidotal Intervention
        T["<b>Fomepizole or Ethanol</b><br>Competitively inhibits ADH enzyme,<br>blocking conversion of DEG to HEAA"] -.-> B
        HD["<b>Urgent Hemodialysis</b><br>Clears parent DEG and toxic metabolites"] -.-> E
    end

Toxic Mechanisms

  1. Parent Compound: DEG itself has sweet taste and pleasant viscosity, making it indistinguishable from harmless propylene glycol.
  2. HEAA Accumulation: The principal metabolite, 2-hydroxyethoxyacetic acid (HEAA), accumulates in proximal renal tubular cells, producing severe cellular necrosis, mitochondrial dysfunction, and renal shutdown.
  3. Clinical Triad of DEG Poisoning:
    • Gastrointestinal Phase (Day 1–2): Severe nausea, vomiting, abdominal pain, diarrhea.
    • Renal Phase (Day 2–5): Sudden-onset oliguria, progression to anuric Acute Kidney Injury, flank pain, severe refractory metabolic acidosis, hyperkalemia.
    • Neurological Phase (Day 5–14+): Lethargy, coma, cranial nerve neuropathies (bilateral facial nerve palsy, vocal cord paralysis), flaccid quadriplegia, and autonomic dysfunction.

Diagnostic Workup In Suspected DEG Toxicity

  • Serum Electrolytes & Blood Gas: High Anion Gap Metabolic Acidosis ($\text{AG} = [\text{Na}^+] - ([\text{Cl}^-] + [\text{HCO}_3^-]) > 16\text{ mEq/L}$).
  • Serum Osmolality & Osmolar Gap:
    • $\text{Calculated Osmolality} = 2[\text{Na}^+] + \frac{\text{Glucose}}{18} + \frac{\text{BUN}}{2.8}$.
    • $\text{Osmolar Gap} = \text{Measured Osmolality} - \text{Calculated Osmolality}$.
    • An elevated gap ($>10–15\text{ mOsm/kg}$) in a child with unexplained anuria strongly indicates toxic alcohol / glycol ingestion.
  • Urinalysis: Shows low specific gravity, renal tubular epithelial cells, granular casts, and trace proteinuria; absence of calcium oxalate crystals (which are characteristic of ethylene glycol, not diethylene glycol).
  • Toxicological Assay: Gas Chromatography–Mass Spectrometry (GC-MS) detects DEG and EG in serum or syrup remnants.

Emergency Management Protocol

flowchart TD
    A["Child with Unexplained Oliguria / Anuria + Syrups Ingestion History"] --> B["<b>Immediate Resuscitation & Labs:</b><br>• ABG (Acidosis), Electrolytes (K+), Creatinine, Anion/Osmolar Gap<br>• Stop all oral liquids/syrups immediately<br>• Confiscate suspect bottle for GC-MS testing"]
    
    B --> C["<b>Antidotal Therapy (Inhibit ADH):</b><br>• 1st Line: IV Fomepizole (15 mg/kg load)<br>• 2nd Line: IV/Oral Ethanol (10% IV or 40% oral spirits)"]
    
    C --> D{"Renal Status & Acidosis"}
    D -->|"Anuria / Hyperkalemia / Severe Acidosis"| E["<b>Immediate Renal Replacement Therapy (RRT):</b><br>• Intermittent Hemodialysis (IHD) or SLED/CRRT<br>• Corrects acidosis, hyperkalemia, and removes DEG/HEAA"]
    D -->|"Preserved Urine Output"| F["Aggressive IV hydration + Sodium bicarbonate infusion<br>Serial monitoring of renal function"]

1. Antidotal Therapy (Alcohol Dehydrogenase Blockers)

  • Fomepizole (4-Methylpyrazole):
    • First-line specific antidote; $8,000\times$ higher affinity for ADH than glycols.
    • Loading Dose: $15\text{ mg/kg}$ IV over 30 minutes.
    • Maintenance: $10\text{ mg/kg}$ IV every 12 hours for 4 doses, then $15\text{ mg/kg}$ q12h until DEG levels $<20\text{ mg/dL}$ or acidosis resolves. (Increase frequency to q4h during hemodialysis).
  • Ethanol (Alternative when Fomepizole unavailable):
    • Competes with DEG for ADH binding. Target blood ethanol concentration: $100–150\text{ mg/dL}$ ($22–33\text{ mmol/L}$).
    • Oral Ethanol (40% spirit): Loading dose $1.8\text{ mL/kg}$ diluted in juice, followed by maintenance infusion/feed $0.2–0.4\text{ mL/kg/hour}$.

2. Renal Replacement Therapy (RRT)

  • Hemodialysis (IHD) / CRRT: Life-saving; parent DEG and HEAA molecules are small, water-soluble, non-protein-bound, and highly dialyzable.
  • Continue hemodialysis until metabolic acidosis corrects and serum DEG is undetectable.

Rational Drug Prescribing In Pediatric Respiratory Illness (IAP Guidelines)

  • The Ineffectiveness of OTC Cough & Cold Formulations:
    • Multiple Cochrane reviews and IAP position statements emphasize that OTC cough syrups (antitussives, antihistamines, decongestants, and expectorants) show zero proven clinical benefit over placebo in acute cough or URTI in children.
    • Associated with substantial morbidity (sedation, respiratory depression, hallucinations, tachycardia, arrhythmias, accidental overdoses, and toxic excipient ingestion).
  • Contraindications & Restrictions:
    • Children $<4\text{ to }6\text{ Years}$: Absolutely avoid all OTC combination cough syrups, dextromethorphan, codeine, chlorpheniramine, and phenylephrine combinations.
    • Codeine: Strict black-box contraindication in children $<12$ years (and up to 18 years post-adenotonsillectomy) due to ultra-rapid CYP2D6 metabolizers suffering fatal respiratory arrest.

Rational Alternatives For Pediatric Cough & Cold

  1. Warm fluids, saline nasal drops, and humidification: Clear nasal crusts and soothe irritated pharyngeal mucosa.
  2. Honey: Proven in randomized controlled trials to be superior to placebo, diphenhydramine, and dextromethorphan in relieving nocturnal cough in children aged $>1\text{ year}$ (never administer to $<1\text{ year}$ due to infant botulism risk).
  3. Simple Paracetamol: For fever and discomfort ($10–15\text{ mg/kg/dose}$), using single-ingredient formulations from verified manufacturers.

Regulatory Reforms In India (CDSCO 2023–2024 Updates)

  • Schedule M Revision: Mandates full quality risk management, raw material qualification, and mandatory testing of every single container of propylene glycol and glycerin for DEG and EG contaminants prior to batch release.
  • Export Certificate Requirement: All pediatric syrup exports from India must possess a Certificate of Analysis from designated government laboratories (e.g., Regional Drugs Testing Labs).
  • Ban on Unscientific Fixed-Dose Combinations (FDCs): Phased withdrawal of irrational multi-ingredient decongestant/antihistamine combinations marketed for infants.